News from #ASCO22 Part 5 - Case Studies of Endometrial Cancer

This session was a case based discussion titled Controversies and Considerations in Adjuvant Advanced Endoemterial Cancer. 

Cases were presented and questions asked of the panel which included a patient advocate, @AdrienneEcana.

#ASCO22 Endometrial Cancer session
First case
Women Presented late- Why?
Did she not know bleeding after menopause was abnormal?
Did change of guidelines ( Neg PAP, Neg HPV screen safe no need to go to gyn for 5 yrs) impact? Covid? pic.twitter.com/4S74Yk8ye0

— Dee Sparacio (@womenofteal) June 7, 2022

1/2 Case 1 #ASCO22 Endometrial cancer #gyncsm
When should EC patient be approached re:clinical trial? @AdrienneEcana "my goal is to destigmatize participation in a clinical trial"
There is time early in treatment to offer option.

— Dee Sparacio (@womenofteal) June 7, 2022

#ASCO22 Endometrial cancer #gyncsm
Obesity is num 1 cause of endometrial cancer.
Case 2
Not Defined menopause.
Her2 testing @ajhingran Radiation important option due to lymph involvement
MMR / Lynch testing should be done . Should POLE be tested? pic.twitter.com/MaFkA8b1qq

— Dee Sparacio (@womenofteal) June 7, 2022

#ASCO22 Endometrial cancer #gyncsm

Mortality in Black women for Endometrial cancer is rising. -Gaillard

"Many black women live in food deserts and improvements in diet is needed." @AdrienneEcana

Endometrial cancer is heading to a more personalized treatment!

— Dee Sparacio (@womenofteal) June 7, 2022

Loved watching advocate and friend @AdrienneEcana present during the Controversies & Considerations in Endometrial Cancer session at #ASCO22. So proud of this amazing advocate . Wish I could have been there in person. #gyncsm pic.twitter.com/rgkbeP2S2C

— Dee Sparacio (@womenofteal) June 7, 2022

Tomorrow catch my last post from ASCO. It included varied Tweets of studies from the meeting that were not necessarily a part of the sessions I viewed.

 

Dee

Every Day is a Blessing! 

#ASCO18 Twitter Highlights June 1 & 2, 2018

What does the first weekend in June mean for oncologists and cancer researchers throughout the world? It means it is time for the  ASCO Annual Meeting in Chicago. I was not able to attend the ASCO Annual Meeting in person this year so I am following the tweets my friends who are attending are sharing.  I was able to take part in a Guideline meeting held at the Meeting on Saturday afterbiib via Webex. So I was there in a sense.
As i the past I will be following the meeting via tweets by doctors , researchers and advocates who are attending. It is not as much fun or exhausting as being there in person but it allows me to keep up to date on the latest results. I'll share the Tweets I found most interesting in the next few blog posts.

I also have been getting e-mail updates from ASCO regarding breaking news and important topics from the meeting. Below the tweets you will find some articles from the ASCO Daily News and ASCO Post that you may find of interest.

First the Tweets:

MATCH TRIAL

MATCH trial results at #ASCO18: sobering reality of precision guided trial enrollment—not always a home run. pic.twitter.com/Pt0XkHSXGj

— Michael Fisch (@fischmd) June 1, 2018

Lynch Syndrome:

Lynch syndrome is common among patient with MSI-high tumors. Via @ASCOPost #ASC018 https://t.co/lJdGKBXvqU pic.twitter.com/bm7JeSxZ7z

— Dr Muin J. Khoury (@MuinJKhoury) June 2, 2018

A genomic study of more than 15,000 #tumor samples presented at #ASCO18 showed that people w/ tumors w/ MSI-H are more likely to have #LynchSyndrome & thus have an increased risk of developing certain types of #cancer . More @ASCOPost https://t.co/lrr0adtMU6 pic.twitter.com/cYQb1yjpKY

— Gil Morgan (@weoncologists) June 2, 2018

Survivorship

Excited to share our survivorship research at #ASCO2018, now published in @JAMAOnc. @AnilSoodMD @MDAndersonNews https://t.co/C0ua5g6rQ4

— Dr. Robert Dood (@DrRobDood) June 2, 2018

Endometrial Cancer

Important finding regarding the importance of weight and #cancer development - High BMI OR gaining large amounts of weight can increase risk of obesity-related cancers like #endometrialcancer #breastcancer #kidneycancer #gyncsm #ASCO18

— Shannon Westin (@ShannonWestin) June 1, 2018

#lcsm #gyncsm #hancsm #asco18 https://t.co/tgyvCJN979

— Danielle Pardue (@Actorielle) June 1, 2018

Clinical Trial Participation:

This highlights one of the many frustrating reasons why clinicians often cannot enroll their patients in #clinicaltrials despite trying, and wanting to! Eligibility criteria need to be more thoughtful, rather than reflexive, standard, or automatic #ASCO18
https://t.co/AL3lbQlmKp

— Thomas LeBlanc, MD (@tomleblancMD) June 2, 2018

ASCO POST or DAILY News Articles:

Lynch Syndrome:
www.ascopost.com/News/58898

Patient Communication:
https://am.asco.org/addressing-patient-communication-challenges

Patient Survivorship Care:
https://am.asco.org/patients-moderate-severe-anxiety-or-depression-symptoms-recognizing-assessing-referring-and

IMPACT Trial :
http://www.ascopost.com/News/58897?email=865aa94a58f0b27b9edd2aa71d80e9a99b924971f7ce90316a0d742b2e9c9b1c

Patient Education and Quality of Care:
https://am.asco.org/patient-education-essential-element-quality-cancer-care
Economics and Value Discussion:
https://am.asco.org/bringing-economics-back-value-discussions

I'm looking forward to the next few days when there will be a greater emphasis on Gynecologic Cancers.

Dee
Every Day is a Blessing!

My Interview on Joinclinicaltrials.com

A few weeks ago Monica Clark, owner and editor of the website http://www.joinclinicaltrials.com/, contacted me about sharing my clinical trial experience on the website's blog. Joinclinicaltrials.com (JCT) is a resource for finding clinical trials and for finding volunteers who would like to participate in clinical trials. The search engine used on the site searches the National Library of Medicine, US Department of Health and Human Services, the National Institute of Health and privately submitted trials for matches to specific medical conditions. The goal of JCT is to "help clinical trial volunteers better understand and evaluate clinical trials that they are considering joining and to provide investigators, CRO’s and sponsors a better way to meet and communicate with these volunteers."

On August 7th my interview was posted on the site and the ovarian cancer section went live. Currently if you type "ovarian cancer" in the search box on the site you will see a listing of 200 clinical trials. And if you want to read about my experience  participating in a clinical trial please visit https://www.joinclinicaltrials.com/blog/women-of-teal-interview-fighting-ovarian-cancer/

Thank you Monica for allowing me to share my experience.


Dee

Every Day is a Blessing!